Osteosarcoma: methotrexate & doxorubicin versus methotrexate, etoposide & ifosfamide
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patientsEur J Cancer. 2007 Mar;43(4):752-61. Epub 2007 Jan 30
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
234 patients with nonmetastatic osteosarcoma were randomized to preoperative chemotherapy of high-dose methotrexate with either doxorubicin or with etoposide and ifosfamide. After a median of 77-month follow-up, patients who had received the etoposide-ifosfamide regimen exhibited a larger percentage of good histologic response. Three- and 5-year overall and event-free survival rates were significa...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE